
|Articles|August 16, 2021
This week on Contemporary OB/GYN®: August 16 to August 20
Author(s)Contemporary OB/GYN Staff
Here's what to look for this week on Contemporary OB/GYN®.
Advertisement
You can expect a variety of topics this week, including:
FDA accepts pembrolizumab as singlea agent for treatment of advanded endometrial cancer
New biomarker could predict immunotherapy benefit in breast cancer
New Hampshire's abortion restrictions
Oral contraceptives and risk of cardiac events in women with congenital long-QT syndrome
The impact of nutrition on gynecological diseases
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA initiates removal of boxed warnings, requests updated labeling for menopausal hormone therapy
2
Study reveals implantation and live birth rates for segmental aneuploid embryos
3
Sage Wyatt, PhD, discusses cardiovascular risk assessment through HDP
4
















